Thomas Helleday publishes a perspective on drugging DNA repair in Science
Helleday Lab congratulates Oskar Fernandez-Capetillo and Dana Branzei becoming new EMBO members
Today Oskar Fernandez-Capetillo and Dana Branzei were elected as members into the prestigious EMBO organisation, which is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, […]
Dr Firas Tarish celebrates his new doctor hat in the City Hall
Thomas Helledays receives ERC Advanced Grant
Thomas Helleday is one of nine scientists receiving a grant of 2.5 million euros over five years from the European Research Council. Research proposed for funding to the ERC should aim high, both with regards to the ambition of the envisaged scientific achievements as well as to the creativity and originality of proposed approaches. The […]
Helleday Laboratory anställer projektledare inför kommande kliniska prövningar
[et_pb_section admin_label=”Section” fullwidth=”off” specialty=”off”][et_pb_row admin_label=”Row” make_fullwidth=”off” use_custom_width=”on” width_unit=”off” custom_width_percent=”70%” use_custom_gutter=”off” padding_mobile=”off” allow_player_pause=”off” parallax=”off” parallax_method=”off” make_equal=”off” parallax_1=”off” parallax_method_1=”off” column_padding_mobile=”on”][et_pb_column type=”4_4″][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”] Helleday Laboratory anställer projektledare inför kommande kliniska prövningar [/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row admin_label=”Row” make_fullwidth=”off” use_custom_width=”on” width_unit=”off” custom_width_percent=”70%” use_custom_gutter=”off” padding_mobile=”off” allow_player_pause=”off” parallax=”off” parallax_method=”off” make_equal=”off” parallax_1=”off” parallax_method_1=”off” parallax_2=”off” parallax_method_2=”off” column_padding_mobile=”on”][et_pb_column type=”1_4″][et_pb_image admin_label=”Image” src=”http://helleday.org/wp-content/uploads/2013/03/LUX_2457.jpg” show_in_lightbox=”off” url_new_window=”off” use_overlay=”off” […]
Thomas Helleday intervjuas i P4 Extra
[et_pb_section admin_label=”section”][et_pb_row admin_label=”row”][et_pb_column type=”4_4″][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”] Professor Thomas Helleday intervjuades av Erik Blix, journalist på Sveriges Radio, för ett inslag i P4 Extra. Inslaget handlade om Nicky McGranahans publikation i Science, publikationen handlar om att använda patientens immunförsvar för att behandla cancer. ”Det här visar på något vi först inte trodde på.” säger […]
Anki lever idag tack vare PARP-hämmare
[et_pb_section admin_label=”section”][et_pb_row admin_label=”row”][et_pb_column type=”4_4″][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”] 2011 kontaktade Anki Thomas Helleday om hans PARP-hämmare, fyra år senare fick hon medicinen och idag lever hon ett liv utan cancer. Anki levde med en cancer med ett CA125 värde på 2055 och sen hon börjat sin nya behandling upptäckt av Thomas Helleday så […]
Thomas Helleday är Årets cancerforskare 2016
[et_pb_section admin_label=”section”][et_pb_row admin_label=”row”][et_pb_column type=”4_4″][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” text_font_size=”14″ use_border_color=”off” border_color=”#ffffff” border_style=”solid”] Under Cancerfondens gala “Nej till cancer” så delades utmärkelsen “Årets cancerforskare” ut. Thomas Helleday tog emot äran och sa “Vi är ett steg från kliniska tester”. Den 11:e januari höll Cancerfonden en gala på Cirkus i Stockholm, galan sändes på TV4 mellan 20:00 och […]